TNFRSF17 and neoplasm: For successful effector functions, it is imperative for CAR T cells to rapidly recognize tumor cells and facilitate CAR receptor binding with the CAR antigen (e.g., CD19, CD20, CD22, BCMA, etc.)expressed on tumor cells (154).